Applications from the field of Pharma & Biopharma | LabRulez ICPMS

Spectroscopy Solutions for Pharmaceuticals

Technical notes

| 2016 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

UV-VISIBLE HARDWARE OPERATIONAL QUALIFICATION

Others

| 2012 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

Applications

| 2022 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Applications

| 2022 | Thermo Fisher Scientific

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Thermo Fisher Scientific

Industries

Pharma & Biopharma

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

Applications

| 2020 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Pharmaceutical Analysis using FTIR: Compliance with European, US, Indian, and Japanese Pharmacopoeia

Technical notes

| 2022 | Agilent Technologies

FTIR Spectroscopy

Instrumentation

FTIR Spectroscopy

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Determination of High Concentration Sodium by Flame Atomic Absorption Spectrophotometry (FAAS) at Different Wavelengths

Applications

| 2016 | Shimadzu

AAS

Instrumentation

AAS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition

Others

| 2019 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

Technical notes

| 2021 | Agilent Technologies

Software, UV–VIS spectrophotometry

Instrumentation

Software, UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Elemental Impurities in Medium- chain Triglycerides According to USP

Applications

| 2022 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma | LabRulez ICPMS

Spectroscopy Solutions for Pharmaceuticals

UV-VISIBLE HARDWARE OPERATIONAL QUALIFICATION

Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

Pharmaceutical Analysis using FTIR: Compliance with European, US, Indian, and Japanese Pharmacopoeia

Determination of High Concentration Sodium by Flame Atomic Absorption Spectrophotometry (FAAS) at Different Wavelengths

USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition

Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

Analysis of Elemental Impurities in Medium- chain Triglycerides According to USP

Related content

Material genetics will be pursued by the AMULET project, which succeeded in the Excellent Research Call

We are trying to succeed with the spin-off company Galochrom

V4+ Conference on Environment and Health in Central Europe